Forsta AP Fonden Acquires 2,100 Shares of Intuitive Surgical, Inc. $ISRG

Forsta AP Fonden raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% in the second quarter, Holdings Channel.com reports. The firm owned 87,500 shares of the medical equipment provider’s stock after purchasing an additional 2,100 shares during the period. Forsta AP Fonden’s holdings in Intuitive Surgical were worth $47,548,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Princeton Global Asset Management LLC bought a new position in Intuitive Surgical during the 2nd quarter valued at approximately $30,000. TD Capital Management LLC increased its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. 1248 Management LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth about $30,000. Bank of Jackson Hole Trust boosted its stake in Intuitive Surgical by 70.5% in the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 31 shares in the last quarter. Finally, First Command Advisory Services Inc. grew its position in Intuitive Surgical by 3,750.0% during the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 75 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 2,067 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total value of $1,136,850.00. Following the completion of the transaction, the vice president directly owned 473 shares in the company, valued at $260,150. This represents a 81.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 98,078 shares of company stock valued at $51,445,892 in the last ninety days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Down 0.7%

ISRG opened at $572.17 on Wednesday. The company’s 50 day moving average is $476.01 and its 200 day moving average is $502.00. The company has a market cap of $205.11 billion, a price-to-earnings ratio of 75.68, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.84 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. Rothschild & Co Redburn lifted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Finally, Robert W. Baird set a $655.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.